奥泰生物：关于2022年限制性股票激励计划首次授予第三个归属期及预留授予第二个归属期归属结果的公告

Core Viewpoint - Aotai Biologics announced the completion of the stock registration for its 2022 restricted stock incentive plan, marking a significant step in its employee incentive strategy [2] Group 1 - The company received a confirmation letter from the Shanghai branch of China Securities Depository and Clearing Corporation on September 12, 2025 [2] - The number of shares vested in this phase is 438,890 shares [2] - The shares were sourced from the company's repurchase of its A-share common stock in the secondary market [2]